References
- Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. International Journal of Radiation Oncology, Biology & Physics 2002; 53: 913–918
- Fosmire H, Hynynen K, Drach GW, Stea B, Swift P, Cassady JR. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. International Journal of Radiation Oncology, Biology & Physics 1993; 26: 253–259
- Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89: 399–403
- Pilepich MV, Krall JM, al-Sarraff M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma—a randomized comparative trial of the radiation therapy oncology group. Urology 1995; 45: 616–623, et al.
- Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WV, Grignon D. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31. Journal of Clinical Oncology 1997; 15: 1013–1021
- Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RD, Storme G, Bernbier J, Kuten A, Steinberg C, Gil T, Collette L, Pierart M. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New England Journal of Medicine 1997; 337: 295–300
- Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. International Journal of Radiation Oncology, Biology & Physics 1984; 10: 787–790
- van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1256
- Kalapurakal JA, Pierce M, Chen A, Sathiaseelan V. Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: A preliminary report. International Journal of Radiation Oncology, Biology & Physics 2003; 57: 654–664
- van Vulpen M, DeLeeuw AAC, Raaymakers BW, can Moorselaar RJA, Hofman P, Lagenduk JJW, Battermann JJ. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results. BJU International 2003; 93: 36–41
- van Vulpen M, De Leeuw JR, Van Gellekom MP, Van Der Hoeven J, De Graeff A, Van Moorselaar RJ, Van Der Tweel I, Hofman P, Lagendijk JJ, Battermann JJ. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. International Journal of Hyperthermia 2003; 19: 402–441
- Deger S, Taymoorian K, Boehmer D, Schink T, Roigas J, Wille AH, Budach V, Wernecke K, Loening SA. Thermoradiotherapy using interstitial self-regulating thermoseeds: An intermediate analysis of a phase II trial. European Urology 2004; 45: 574–580
- Pollack A, Zagers GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. International Journal of Radiation Oncology, Biology & Physics 2002; 53: 1907–2105
- Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. International Journal of Radiation Oncology, Biology & Physics 2002; 53: 1111–1116